3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Recruiting
2
Completed
2
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Plasma cell
2
Other hematologic neoplasm
2
Lymphoid
2
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
310
Lymphoma
306
Lymphoma, Non-Hodgkin
227
Lymphoma, Large B-Cell, Diffuse
220
Lymphoma, Follicular
201
Leukemia, Lymphocytic, Chronic, B-Cell
168
Lymphoma, B-Cell
147
Recurrence
124
Burkitt Lymphoma
117
Lymphoma, Mantle-Cell
112
Leukemia, Myeloid, Acute
106
Leukemia
103
Hodgkin Disease
102
Multiple Myeloma
95
Lymphoma, B-Cell, Marginal Zone
87
Neoplasms
80
Myelodysplastic Syndromes
69
Lymphoma, T-Cell, Peripheral
62
Hematologic Neoplasms
61
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
58
Lymphoma, T-Cell
52
Lymphoma, T-Cell, Cutaneous
44
Waldenstrom Macroglobulinemia
41
Leukemia, Biphenotypic, Acute
35
Mycosis Fungoides
31
Lymphoproliferative Disorders
30
Leukemia, B-Cell
30
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Breast Neoplasms
28
Myeloproliferative Disorders
26
Interventions
gamma-Globulins
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Saline Solution
1
Immunoglobulins
1
Clavulanic Acid
1
Ciprofloxacin
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Agammaglobulinemia
×
Lymphoid
×
Clear all
NCT05645107
2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3
Recruiting
386 enrolled
NCT05678621
2024-04-19
RATIONALISE
Monash University
Phase 2/3
Recruiting
300 enrolled